AI assistant
Sending…
ALNYLAM PHARMACEUTICALS, INC. — Director's Dealing 2012
Jun 25, 2012
29981_dirs_2012-06-25_4abf872a-bc32-40bf-a199-42012ac513ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2012-06-21
Reporting Person: CLARKE JOHN K (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-21 | Stock Option (Right to Buy) | $11.33 | A | 15000 | Acquired | 2022-06-21 | Common Stock (15000) | Direct |
More from ALNYLAM PHARMACEUTICALS, INC.
Board/Management Information
2026
May 27
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 25